Companies Mentioned

Teva Pharmaceuticals USA, Inc.

Category
Title
Summary
Date
Commentaries
Patent Law

The Federal Circuit has resolved prior inconsistencies in its case law and established a bright line rule to define infringement in product-by-process claims, holding that such infringement requires practice of the claimed process by the alleged infringer. In Abbott Labs v. Sandoz, 566 F.3d 1282 (Fed. Cir. 2009), the Federal…
Posted:
07/13/2009
Summaries
Patent Law >
New Judicial Opinions

On summary judgment, the district court found in favor of plaintiffs Eisai Co., Ltd. and Eisai, Inc. (collectively “Eisai”) with respect to the validity and enforceability of 552 patent.  Opinion, pp. 1-2, citing Eisai Co. v. Teva Pharms. USA, Inc., No. 03 Civ. 9223 (S.D.N.Y. Oct. 5, 2006); Eisai Co.…
Date of ruling:
07/21/2008
The most advanced document                
         management system in the world.

Only $59 / person / month
FeaturesLawLoop Demo
FeaturesWelcome to the Future
Play LawLoop Demo